-OONO: rebounding from nitric oxide.
Beckman
J S
JS
D000280:Administration, Inhalation; D000818:Animals; D004730:Endothelium, Vascular / Q000378:metabolism; D011464:Epoprostenol / Q000096:biosynthesis; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D017665:Hydroxyl Radical / Q000378:metabolism; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000378:metabolism*; D009566:Nitrates / Q000378:metabolism* / Q000494:pharmacology; D009569:Nitric Oxide / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism*; D009585:Nitrogen Dioxide / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D011014:Pneumonia / Q000378:metabolism; D044262:Prostaglandin H2; D011463:Prostaglandins H / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D013481:Superoxides / Q000378:metabolism; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000378:metabolism
D006454:Hemoglobins; D009566:Nitrates; D011463:Prostaglandins H; D013481:Superoxides; C039642:peroxynitric acid; D009569:Nitric Oxide; D017665:Hydroxyl Radical; C002744:3-nitrotyrosine; D044262:Prostaglandin H2; D014443:Tyrosine; D011464:Epoprostenol; D009585:Nitrogen Dioxide